期刊文献+

双吗啉取代吡啶锌和铜配合物的合成、表征及抗癌活性初步研究

Preliminary Studies of Synthesis,Characterization and Anticancer Activity of Zinc and Copper Complexes Based on Bis-Morpholine Substituted Pyridine
下载PDF
导出
摘要 目的研究双吗啉取代吡啶锌、铜配合物(Mor_(2)-Py-Zn和Mor_(2)-Py-Cu)的合成,并探讨其抗癌活性。方法以进入临床试验的拮抗剂AMD3100为先导化合物,设计、合成Mor_(2)-Py-Zn和Mor_(2)-Py-Cu,并以高分辨质谱法对它们进行表征。利用X射线单晶衍射法测定晶体结构,紫外-可见吸收光谱分析配合物与小牛胸腺DNA(CT-DNA)的相互作用,并利用形态学和MTT实验探索配合物对胶质瘤细胞的毒活性。结果Mor_(2)-Py-Zn的晶体结构属于正交晶系,Pbca空间群,吡啶N、两个吗啉N及两个硝酸根的O原子与Zn^(2+)形成了N3O2五配位的三角双锥构型。Mor_(2)-Py-Zn和Mor_(2)-Py-Cu均与CT-DNA在溶液中有一定的相互作用。Mor_(2)-Py-Zn和Mor_(2)-Py-Cu对U87的抑制活性都较弱,而对于U251则能显著抑制其增殖。MTT实验表明,Mor_(2)-Py-Zn和Mor_(2)-Py-Cu对于U251细胞的IC_(50)分别为18.11μmol/L和14.66μmol/L。结论Mor_(2)-Py-Zn和Mor_(2)-Py-Cu均表现出对U251胶质瘤细胞的抑制活性,具有继续深入研究其抗癌机理的价值。 Objective To research the synthesis and anticancer activities of zinc and copper complexes based on bis-morpholine substituted pyridine(Mor_(2)-Py-Zn and Mor_(2)-Py-Cu).Methods Taking the antagonist AMD3100,which entered the clinical trial,as the lead compound,Mor_(2)-Py-Zn and Mor_(2)-Py-Cu were designed and synthesized,and characterized by high resolution mass spectrometry.The crystal structure was determined by X-ray single crystal diffraction.The interaction between complexes and calf thymus DNA(CT-DNA)was studied by UV-Vis absorption spectroscopy,and the cytotoxicity against glioblastoma cells was further studied by morphological analysis and MTT assays.Results Mor_(2)-Py-Zn belongs to the orthorhombic system,pbca space group,pyridine N,two morpholine N and two nitrate O atoms form a triangular bipyramidal configuration of N3O2 pentagram with Zn~(2+).Both Mor_(2)-Py-Zn and Mor_(2)-Py-Cu interacted with CT-DNA in solution to some extent.The two complexes showed weak inhibitory activity against U87,but obviously inhibited the proliferation of U251.Further,MTT assay showed that the IC_(50)of Mor_(2)-Py-Zn and Mor_(2)-Py-Cu for U251 cells were 18.11μmol/L and 14.66μmol/L,respectively.Conclusion Both Mor_(2)-Py-Zn and Mor_(2)-Py-Cu are valuable for further study of their anticancer mechanism,especially for U251 cells.
作者 汪清清 潘耀 游双 黄鑫 熊衍才 王小波 WANG Qing-qing;PAN Yao;WANG Xiao-bo(School of Pharmacy,Xianning Medical College,Hubei University of Science and Technology,Xianning Hubei 437100,China)
出处 《湖北科技学院学报(医学版)》 2024年第4期292-296,共5页 Journal of Hubei University of Science and Technology(Medical Sciences)
基金 湖北省教育厅重点项目(D20212802)。
关键词 锌配合物 铜配合物 抗癌 人胶质瘤细胞 DNA相互作用 晶体结构 Zinc complex Copper complex Anticancer Glioma cells Interaction with DNA Crystal structure
  • 相关文献

参考文献10

二级参考文献55

  • 1柳占彪,王鼎,王淑珍,哈斯,李浦维.齐墩果酸的降糖作用[J].中国药学杂志,1994,29(12):725-726. 被引量:39
  • 2谭洁,沈志祥,耿伟.熊果酸诱导结肠癌HT-29细胞凋亡的实验研究[J].中华肿瘤杂志,2006,28(2):99-102. 被引量:16
  • 3Huang, D.; Ding, Y.; Li, Y.; Zhang, W.; Fang, W. M.; Chen, X. G. Cancer Lett. 2006, 233(2), 289.
  • 4Ginerlarza, E. M.; Manez, S.; Recio, M. C.; Giner, R. M.; Prieto, J. M.; Cerdanicolas, M.; Rios, J. L. Eur. J. Pharmacol. 2001, 428(1), 137.
  • 5Liu, J. J. Ethnopharmacol.2005, 100(1), 92.
  • 6Ali, M. S.; Jahangir, M.; Hussan, S. S.; Choudhary, M. I. Phytochemistry 2002, 60(3), 295.
  • 7Huang, M. T.; Ho, C. T.; Wang, Z. Y.; Ferraro, T.; Lou, Y. R.; Stauber, K.; Ma, W.; Georgiadis, C.; Laskin, J. D.; Conney, A. H. Cancer Res. 1994, 54, 701.
  • 8Rhew, T. H.; Park, S. M.; Park, K. Y.; Chung, H. Y.; Hah, J. C.; Lee, C. K. Yakhak Hoechi 1992, 36(6), 529.
  • 9Banno, N.; Akihisa, T.; Tokuda, H.; Yasukawa, K.; Higashihara, H.; Ukiya, M.; Watanabe, K.; Kimura, Y.; Hasegawa, Y.; Hasegawa, J, I.; Nishino, H. Biosci. Biotechnol. Biochem. 2004, 68(1), 85.
  • 10Sohn, K. H.; Lee, H. Y.; Chung, H. Y.; Young, H. S.; Yi, S. Y.; Kim, K. W.Cancer Lett. 1995, 94(2), 213.

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部